Stryker Corporation (SYK)
Cash ratio
| Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | ||
|---|---|---|---|---|---|---|
| Cash and cash equivalents | US$ in thousands | 4,011,000 | 3,652,000 | 2,971,000 | 1,844,000 | 2,944,000 |
| Short-term investments | US$ in thousands | 89,000 | 750,000 | 82,000 | 84,000 | 75,000 |
| Total current liabilities | US$ in thousands | 7,794,000 | 7,616,000 | 7,921,000 | 6,303,000 | 4,549,000 |
| Cash ratio | 0.53 | 0.58 | 0.39 | 0.31 | 0.66 |
December 31, 2025 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($4,011,000K
+ $89,000K)
÷ $7,794,000K
= 0.53
Peer comparison
Dec 31, 2025
Company name
Symbol
Cash ratio
Stryker Corporation
SYK
0.53
Abbott Laboratories
ABT
0.56
CONMED Corporation
CNMD
0.09